Tissue plasminogen activator (tPA) inhibits plasmin degradation of fibrin. A mechanism that slows tPA-mediated fibrinolysis but does not require alpha 2-antiplasmin or leakage of intrinsic plasminogen
about
Targeting therapeutics across the blood brain barrier (BBB), prerequisite towards thrombolytic therapy for cerebrovascular disorders-an overview and advancementsThe interplay between tissue plasminogen activator domains and fibrin structures in the regulation of fibrinolysis: kinetic and microscopic studies.
P2860
Tissue plasminogen activator (tPA) inhibits plasmin degradation of fibrin. A mechanism that slows tPA-mediated fibrinolysis but does not require alpha 2-antiplasmin or leakage of intrinsic plasminogen
description
1995 nî lūn-bûn
@nan
1995 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Tissue plasminogen activator ( ...... akage of intrinsic plasminogen
@ast
Tissue plasminogen activator ( ...... akage of intrinsic plasminogen
@en
type
label
Tissue plasminogen activator ( ...... akage of intrinsic plasminogen
@ast
Tissue plasminogen activator ( ...... akage of intrinsic plasminogen
@en
prefLabel
Tissue plasminogen activator ( ...... akage of intrinsic plasminogen
@ast
Tissue plasminogen activator ( ...... akage of intrinsic plasminogen
@en
P2860
P356
P1476
Tissue plasminogen activator ( ...... akage of intrinsic plasminogen
@en
P2093
P2860
P304
P356
10.1172/JCI117949
P407
P577
1995-06-01T00:00:00Z